GI NURSES CONNECT powered by COR2ED

Independent Medical Education from COR2ED developed by GI NURSES CONNECT, experts in GI & LIVER (HCC) oncology nursing

[OncoAlert @OncoAlert]

Lung cancer 🫁 update from #ASCO26
👉 https://t.co/Tik3fC02aR

Renowned lung cancer experts join our collaborators at COR2ED at ASCO 2026 to discuss breaking data emerging from the meeting. Watch the video updates for insights on HER2-mutant non-small cell lung cancer (NSCLC) from Drs Herbert Loong and Isabel Preeshagul, and analysis of other key lung cancer trial data from Prof. Mark Socinski.
#LungCancer #NSCLC #SCLC
@herbloong @ipreeshagul

[OncoAlert @OncoAlert]

GI and hepatobiliary cancer update from ASCO 2026
Medical oncologist Prof. Hans Prenen joins @COR2EDMedEd in Chicago to share his expert insights on the latest data in colorectal, pancreatic, and liver cancers presented at ASCO 2026. How will late-breaking data impact clinical practice? Watch his video update to find out.

https://t.co/cJdpVtKQUF

[OncoAlert @OncoAlert]

Breast Cancer Update from ASCO 2026 : Watch Dr @PTarantinoMD joins @COR2EDMedEd in Chicago to share his views on the latest breast cancer data emerging from ASCO 2026. How will new developments impact clinical practice? Watch his update to find out!

https://t.co/SAFoLcxl4V

[OncoAlert @OncoAlert]

Dear Colleagues at #ASCO26
Get expert insights on new #ProstateCancer data emerging from ASCO 2026. Prof. Evan Yu joins @COR2EDMedEd live in Chicago to share his views on how new trial data presented at the meeting could impact the clinical management of patients with prostate cancer. Watch his conference update now.

Watch here👉 https://t.co/OouXnsouqm

[GI NURSES CONNECT powered by COR2ED @ginursesconnect]

📣#GICancer highlights from #ASCO26!

Prof. @HPrenen shares his expert insights on key #ColorectalCancer, #PancreaticCancer & #LiverCancer #trialdata from #EMERALD-3, #BREAKWATER & #RASolute 302

How will these data impact clinical practice? Watch his video to find out!

🤝 Programme endorsed by @WarOnCancer

📺See more updates from @ASCO in 𝘏𝘌𝘙2-mutant #NSCLC, #lungcancer, #ProstateCancer & #BreastCancer

>> https://t.co/RLiQL3weSL

This educational programme is supported by COR2ED
#MedEd #HCC #CRCSM #CRC #CancerNurses

[OncoAlert @OncoAlert]

Lung cancer 🫁 update from #ASCO26
👉 https://t.co/TZS21R524b

Renowned lung cancer experts join our collaborators at @COR2EDMedEd at ASCO 2026 to discuss breaking data emerging from the meeting. Watch the video updates for insights on HER2-mutant non-small cell lung cancer (NSCLC) from Drs Herbert Loong and Isabel Preeshagul, and analysis of other key lung cancer trial data from Prof. Mark Socinski.
#LungCancer #NSCLC #SCLC
@herbloong @ipreeshagul

[COR2ED @COR2EDMedEd]

📢 #ASCO26 is nearly here, keep a look out for our conference update!

In this video, Dr @ipreeshagul introduces the medical experts who will be joining us at ASCO

➡️Dr @herbloong: 𝘏𝘌𝘙2-mutant NSCLC (along with Dr Preeshagul)

➡️Prof. @MarkSocinski: #NSCLC / #LungCancer

➡️Prof. Evan Yu: #ProstateCancer

➡️Prof. @HPrenen: #GIcancer: #HCC, #LiverCancer, #CRC, #PanCan

➡️ Dr @PTarantinoMD: #BreastCancer

🎬 Keep checking back to see the videos as soon as they’re released: https://t.co/kSgc3cEdxs

𝘏𝘌𝘙2-mutant NSCLC update supported by an Independent Educational Grant from Bayer. All other updates supported by COR2ED

#MedEd #OncTwitter #OncMedEd

[GI NURSES CONNECT powered by COR2ED @ginursesconnect]

May is #OncologyNursingMonth 🩺

We want to recognise #cancernurses around the world, working tirelessly to provide the best care for their patients

Thank you for all you do! 💐

From @COR2EDMedED, @GUNURSESCONNECT and GI NURSES CONNECT

#IND26 #OncologyNursing

[GI NURSES CONNECT powered by COR2ED @ginursesconnect]

Useful insights on trial data, safety and real-world considerations for peri-operative immunotherapy in gastric and GEJ cancer.

#MedEd

[GI CONNECT powered by COR2ED @giconnectInfo]

Get expert insights on the peri-operative use of immunotherapy in gastric and GEJ cancer

Explore
- the current treatment landscape
- latest trial data
- clinical impact
- safety considerations
and more!

📺 From Assoc. Prof. Sam Klempner (@KlempnerSam)

Endorsed by @WarOnCancer, @StoCANcer & Esophageal Cancer Action Network

Supported by an Independent Educational Grant from AstraZeneca US

[GI NURSES CONNECT powered by COR2ED @ginursesconnect]

LEVIATHAN data indicate lenvatinib may offer greater second-line efficacy than sorafenib after atezolizumab plus bevacizumab in unresectable HCC, even in patients with primary resistance to immunotherapy.

[HCC CONNECT powered by COR2ED @hccconnectinfo]

Get expert insights on the LEVIATHAN publication

>> Evaluating lenvatinib versus sorafenib as 2nd line treatment post atezolizumab plus bevacizumab for #HCC

📺 Prof. David Pinato (@DJPinato) discusses key findings & implications for practice

View/download the infographic: https://t.co/2jfN8TNayV

🤝 Programme endorsed by @EuropeLiver, @BlueFaeryLiver, @GlobalLiver & @ESDO_tweets

This programme is supported by an independent educational grant from Eisai Europe Limited. Eisai Europe Limited has financially supported this activity and has had no influence on its creation or content.

#MedEd #HCC

[GI NURSES CONNECT powered by COR2ED @ginursesconnect]

We are proud to share that more than 50,000 HCPs around the world follow @COR2EDMedEd's programmes to stay up to date with the latest science, and provide their patients with the best possible care 🎉

~ GI NURSES CONNECT is an initiative of COR2ED ~

👏 Over 25k HCPs subscribe to the COR2ED YouTube channel to see educational videos as soon as they're released

👏 More than 25k followers stay up to date with #MedEd on the COR2ED social media channels on X, LinkedIn, Instagram, and BlueSky

Are you part of our community yet?

🎓 Follow us for engaging videos, podcasts, publications, micro learnings, and more!

Our programmes are developed by renowned medical experts and endorsed by Medical Societies & Patient Advocacy Groups ✅

Come and follow us on YouTube! https://t.co/OUydLEKHH8

#medicaleducation #MedTwitter #OncTwitter #GITwitter

[GI CONNECT powered by COR2ED @giconnectInfo]

🚨 New on-demand resources! 🚨

Expert insights from the latest gastric and gastroesophageal cancer data from ESMO 2025

📺 Newly-released video & slides from a virtual Experts Knowledge Share

Meeting Chair: Dr @LizzySmyth1 (UK)
Co-Chairs: Prof. Aziz Zaanan (France) & Prof. Markus Moehler (Germany)

The faculty shares insights for clinical practice & discusses data from key clinical trials:

✔️ FORTITUDE-101
✔️ INTEGRATE IIb
✔️ MATTERHORN
✔️ PHERFLOT
✔️ SKYSCRAPER-07
✔️ LEAP-014

Get the slides: https://t.co/gaepoFSYD4

🤝 This programme is endorsed by @ESDO_tweets, @dice_europe & @WarOnCancer

Supported by an Independent Educational Grant from Amgen

#MedEd #MedTwitter #ESMO25

[GI NURSES CONNECT powered by COR2ED @ginursesconnect]

‘Peri-operative use of immunotherapy in gastric and GEJ cancer’

A new #MedEd video from Assoc. Prof. Sam Klempner📺

Get expert insights on the current treatment landscape, latest trial data, clinical impact, safety considerations, and more

🤝Endorsed by @WarOnCancer & Esophageal Cancer Action Network

🔗 View the slides: https://t.co/zjSIFaoiNJ

Supported by an Independent Educational Grant from AstraZeneca US

#RN #OncologyNursing

[GI NURSES CONNECT powered by COR2ED @ginursesconnect]

Gastric/gastroesophageal cancer data from #ESMO 2025: Experts Knowledge Share from @giconnectInfo!

🗓️ 19th November
⏰ 17:00 - 18:15 CET / 11:00 - 12:15 EST

🔗 Register now to secure your place! https://t.co/tPOgpQvm5S

Join your peers in a post-ESMO interactive webinar to explore new data and the potential implications for clinical practice

The panel will discuss what’s new for
- targeted therapy & IO
- the peri-operative space
- esophageal squamous cell carcinoma (ESCC)

🗣️ PLUS: Q&A between speakers + attendees

Don’t miss it!

🤝Endorsed by: @dice_europe

This independent programme is supported by an educational grant from Amgen

#ESMO25 #MedEd #GIcancer #gastriccancer #ESMO2025 🎬

[GI NURSES CONNECT powered by COR2ED @ginursesconnect]

🎉 @COR2EDMedEd now has over 20,000 YouTube subscribers! 🎉

GI NURSES CONNECT is an initiative of COR2ED - come and find us on YouTube!

Join over 20k healthcare professionals who follow us on YouTube to stay up to date with high-quality, engaging medical education programmes from world-renowned experts and in collaboration with Medical Societies and Patient Advocacy groups 🎓

Subscribe ▶️ https://t.co/OUydLEKHH8

#OncTwitter #MedTwitter #MedEd

[GI NURSES CONNECT powered by COR2ED @ginursesconnect]

📢Just released!

Gastric & #gastroesophageal cancer update from #ESMO25!

�� Dr @LizzySmyth1 shares her #gastric & GE cancer highlights & reviews the latest data from #MATTERHORN trial

See more updates from #ESMO
▶️ https://t.co/COiahosVYp

This independent programme is supported by COR2ED

#MedEd #GastricCancer #GIcancer

[COR2ED @COR2EDMedEd]

📢 Come and visit us in Berlin at #ESMO25!

We'll be at Booth 4025 offering FREE profile headshots from our professional photographer, and showcasing our range of high-quality Independent #MedicalEducation programmes across multiple therapy areas.

See you there!

#IME #MedTwitter #MedEd #OncTwitter #ESMO2025 #ESMO
@myESMO